Eric Borges
- Immunology and Allergy top 0.2%
- Cell Adhesion Molecules Research 15
- Immunology top 2%
- Immunotherapy and Immune Responses 8
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 3
- Oncology top 5%
- CAR-T cell therapy research 4
- Hematology top 5%
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 7
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Dietmar VestweberAlf HamannMartin SteegmaierRupert HallmannErkki RuoslahtiMax LöhningHarald RenzRolf Bräuer
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Eric Borges
28 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Immunology and Allergy 1.3k
- Immunology 1.4k
- Oncology 599
- Hematology 216
- Cancer Research 247
Countries citing papers authored by Eric Borges
This map shows the geographic impact of Eric Borges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Borges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Borges more than expected).
Fields of papers citing papers by Eric Borges
This network shows the impact of papers produced by Eric Borges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Borges. The network helps show where Eric Borges may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Borges, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 9 | |
| 2 | 2019 | 1 | |
| 3 | 2013 | 73 | |
| 4 | 2012 | 4 | |
| 5 | 2011 | 2 | |
| 6 | 2010 | 1 | |
| 7 | Fully human Anti-HER3 monoclonal antibodies (mAbs) inhibit oncogenic signaling and tumor cell growth in vitro and in vivo | 2008 | 14 |
| 8 | 2003 | 91 | |
| 9 | 2002 | 64 | |
| 10 | 2001 | 87 | |
| 11 | 2000 | 240 | |
| 12 | 1999 | 21 | |
| 13 | 1998 | 150 | |
| 14 | 1997 | 236 | |
| 15 | 1997 | 95 | |
| 16 | 1997 | 25 | |
| 17 | P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissuesbreakdown → | 1997 | 637 |
| 18 | 1997 | 63 | |
| 19 | 1995 | 275 | |
| 20 | 1994 | 43 |
About Eric Borges
Eric Borges is a scholar working on Immunology and Allergy, Immunology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 28 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (15 papers), Immunotherapy and Immune Responses (8 papers), Protease and Inhibitor Mechanisms (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), T-cell and B-cell Immunology (5 papers), CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Immunology and Allergy (1.3k citations), Immunology (1.4k citations), Oncology (599 citations), Hematology (216 citations) and Cancer Research (247 citations). Eric Borges has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Dietmar Vestweber, Alf Hamann, Martin Steegmaier, Rupert Hallmann, Erkki Ruoslahti, Max Löhning, Harald Renz, Rolf Bräuer, F Austrup and Andreas Radbruch. Their work appears in journals such as Blood, Journal of Biological Chemistry, Cancer Research, Molecular Cancer Therapeutics and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.